Journal · Updated 2026-08-11
OrderlyMeds Review 2026: $149 Semaglutide That Competes, $299 Tirzepatide That Doesn't
By the GLP1ProviderFinder Research Desk · Medically reviewed by Dr. A. Goher, MD · Last reviewed 2026-08-11 · How we verify
Short answer — August 2026
OrderlyMeds is two placements under one roof: semaglutide at one forty-nine all-in — level with the Ivim/one-forty-nine cluster, twenty over bmiMD's floor, thirty under Henry — and tirzepatide at two ninety-nine, a hundred-twenty-plus over the flat tier and precisely at FDA-approved Zepbound's starter-vial price. Provider-stated status, ad matching checkout per our records. The verdict splits accordingly: the semaglutide figure belongs on value shortlists; the tirzepatide figure walks straight into the brand comparison and, for most buyers, loses it.
The split, and the questions
On semaglutide, one forty-nine without a stated membership is a clean number — the diligence is the standard pair (pharmacy name plus verification; confirm dose-flatness and exit terms in writing) and, cleared, OrderlyMeds is a legitimate alternative for buyers who want a stated mid-value price from this operator rather than chasing the floor. On tirzepatide, the arithmetic needs no diligence: two ninety-nine compounded versus two ninety-nine for the FDA-approved 2.5-milligram vial — and versus four forty-nine at maintenance, a hundred-fifty premium buying agency review, sealed dosing, and zero compounding-lane exposure — is a comparison the compounded side wins only on the dose-flat technicality (compounded stays two ninety-nine at maintenance while the brand ladder rises). Whether that technicality is worth the certainty trade is each buyer's call; the flat-tier programs at one sixty-nine-to-one seventy-nine make the same technical point for a hundred-twenty less.
Questions people ask
How much does OrderlyMeds cost?
$149/month all-in for compounded semaglutide and $299 for tirzepatide — provider-stated, with advertised prices matching checkout in our records. No membership line.
Is OrderlyMeds' $149 semaglutide a good deal?
It's inside the value cluster: $20 over bmiMD's $129 floor, level with Ivim's membership-included $149, under Henry's $179. Clear the standard checks (pharmacy name + verification, dose-flatness and exit terms in writing) and it's a legitimate shortlist entry.
Why compare OrderlyMeds' tirzepatide to Zepbound?
Because $299 compounded meets FDA-approved Zepbound's $299 starter-vial rung exactly — and sits $150 under the $449 maintenance rung that buys agency review and sealed dosing. Compounded's only edge at this price is staying flat at maintenance; the $169–$179 flat tier makes that argument $120–$130 cheaper.
This article is pricing research, not medical advice. Verify figures at the provider's checkout. Nothing here is medical advice.